DelveInsight’s Burns Market Insights report proffers a detailed comprehension of Burns market size by treatment, epidemiology, emerging therapies, Burns market drivers, market barriers, and ongoing clinical trials. The report also provides an understanding of Burns market share of the individual therapies, current and forecasted Burns market size from 2018 to 2030 segmented into 7MM (the US, EU5 (the UK, Italy, Spain, France, and Germany), and Japan).
Some of the major takeaways from the Burns Market Report:
- The Burns market size was USD 830 million in 2020 in the United States. DelveInsight estimates suggest that the United States had the highest incident population of burn injuries that required medical treatment. The market size of Burns is expected to grow at a CAGR of 1.96% in the 7MM for the study period 2018-2030.
- The Burns pipeline therapies include DenovoSkin, CellMist System, MW-III, and others, which may improve the treatment dynamics in the upcoming future.
- Major pharma giants working proactively in the Burns therapeutic market include CUTISS AG, Skingenix, Polynovo, Mallinckrodt Pharmaceuticals, Kerecis, MediWound Germany GmbH, Kaken Pharmaceutical Co., Avita Medical, Vericel Corporation, KeraNetics, Integra Life Sciences Corporation, Medline Industries, Anika Therapeutics, ACell, Amryt Pharma, Skingenix, RenovaCare, and many more.
- The Burns market is expected to be driven by factors such as the increasing incidence, availability of a wide range of treatment options, and advancements in burn care treatments and products.
- The Burns market may be hampered by several factors including stringent regulatory guidelines for the approval of new treatment or medicine and high cost for the treatment.
- A major breakthrough in Burns treatment is a bio-engineered DenovoSkin which is being developed by CUTISS AG.
Download Burns Market sample to understand the comprehensive treatment scenario @ https://www.delveinsight.com/report-store/burns-market
Burns: Overview
A Burn takes place when the skin comes into contact with a heat source. Burns can occur from many different sources. The most common sources that cause Burns are fire/flame, scalds, hot objects, electrical, and chemical agents, respectively. Burns is a common injury seen in emergency departments around the world. Even as emergency management improves, Burns continues to have significant morbidity and mortality.
Request for a Webex demo of the report @ https://www.delveinsight.com/report-store/burns-market
Burns Epidemiology Segmentation
DelveInsight’s analysis indicates that the majority of Burns injury cases taking treatment are males due to most Burn cases occurring at the workplace making males more vulnerable to Burns. There were 411,066 male and 251,944 female cases of treated burn injuries in 2020 in the United States.
In the same year, the Burns severity-specific estimated cases were observed to be 144,536, 387,198, 19,890, and 111,386 for first-degree, second-degree, third-degree, and unspecified, respectively in the United States.
The Burns Market Report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:
- Incident Cases of Burns Patient Requiring Treatment
- Gender-specific Incident Cases of Treated Burn Injuries
- Etiology-specific Incident Cases of Treated Burn Injuries
- Severity-specific Incident Cases of Treated Burn Injuries
- Incident Cases of Hospitalized Burns Patients
Know how Burns Epidemiological Trends are going to look like in 2030 for the 7 MM by downloading @ https://www.delveinsight.com/report-store/burns-market
In the current market scenario, the standard treatment for Burns involves medications, wound dressings, therapy, and surgery. The Burns treatment goal is to control pain, remove dead tissue, prevent infection, reduce scarring risk, and regain function. The Burns treatment depends on the severity of the burn. Currently, some major pharmaceutical companies like Kerecis, Polynovo, Mallinckrodt, are marketing Burns treatment therapies like Kerecis Omega3, NovoSorb BMT, and Stratagraft.
Despite the widespread availability of safe and effective Burns medications and surgery options, pharmaceuticals like Cutiss AG, Skingenix, and many more are developing novel Burns treatment therapies. One major breakthrough therapeutic product DenovoSkin is being developed by CUTISS AG which is bio-engineered with a thick, double layer, robust structure. DenovoSkin is a patented, personalized, autologous bio-engineered human skin graft classified as Advanced Therapy Medical Product (ATMP). DenovoSkin has successfully completed Phase I. Another therapeutic product is MW-III, by Skingenix, which is a topical product being evaluated for second-degree burns in adult patients.
To know about more pipeline therapies under different development phases visit @ https://www.delveinsight.com/report-store/burns-market
The rise in the number of incident Burn cases can be considered as a prominent factor for Burns market surge in the coming years. The Burns market is expected to show positive growth, mainly attributed to factors like increase in research and development activities, rise in the number of clinical studies, increasing number of surgical procedures, the launch of upcoming therapies, and the availability of a wider range of treatment options.
However, unreported and undiagnosed Burns cases and the absence of effective treatment are some of the major blockades in the Burns market growth. Apart from that, stringent regulatory guidelines are also applied for the approval of new treatment with the high cost for the treatment of Burns which may act as setbacks.
Scope of the Burns Market Report
- Study Period: 2018-30
- Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.]
- Key Companies: Mallinckrodt Pharmaceuticals, Polynovo, Kerecis, CUTISS AG, Skingenix, MediWound Germany GmbH, Kaken Pharmaceutical Co., Avita Medical, Vericel Corporation, KeraNetics, Integra Life Sciences Corporation, Medline Industries, Anika Therapeutics, ACell, Amryt Pharma, Skingenix, RenovaCare, and many more
- Key Burns Pipeline Therapies: DenovoSkin, CellMist System, MW-III, and others
- Therapeutic Assessment: Burns current marketed and emerging therapies
- Market Dynamics: Burns market drivers and barriers
- Competitive Intelligence Analysis: PEST Analysis
- Unmet Needs
- KOL’s views
- Analyst’s views
- Market Access and Reimbursement
Table of Contents
| 1 | Key Insights |
| 2 | Burns Report Introduction |
| 3 | Burns Market overview at a glance |
| 4 | Disease Background and Overview: Burns |
| 5 | Burns Epidemiology and Patient Population (7MM) |
| 6 | Burns: Country Wise-Epidemiology |
| 7 | Treatments & Medical Practices in Burns |
| 8 | Current Treatment in Burns |
| 9 | Burns Emerging Treatment |
| 10 | Burns Competitive Analysis |
| 11 | Burns: Seven Major Market Analysis |
| 12 | 7MM: Burns Country-wise Market Analysis |
| 13 | Burns United States Market Size |
| 14 | Burns EU5 Market Size |
| 15 | Burns Japan Market Size |
| 16 | Burns Market Drivers |
| 17 | Burns Market Barriers |
| 18 | Report Methodology |
| 19 | DelveInsight Capabilities |
| 20 | Disclaimer |
| 21 | About DelveInsight |
DelveInsght’s Competitive Intelligence Service includes a multidimensional coverage, helping to keep track of competitors and gain traction in the dynamic market by overcoming the challenges and expediting business growth through a strategic and tactical approach.
Related Reports:
- Thymic Carcinoma Market
- Asphyxia Market
- Acute Agitation And Aggression Market
- HPV-Induced Cancers Market
- Diagnostic Imaging Equipment Market
- Epilepsy Market
- Bradykinesia Market
- Immunologic Deficiency Syndrome Market
- Wilms Tumor Market
- Advanced Wound Care Market
- Defibrillators Market
- Diagnostic Imaging Equipment Market
- Pulse Oximeters Market
- Achromatopsia Market
- Cataplexy Market
Related Blogs:
- Social Determinants of Health and their Impact on COVID-19
- Top Drugs To Watch in HIV (2025)
- Gene Therapy for Hemophilia: Progress and Setbacks
- IgA Nephropathy – In-depth Assessment of the Emerging Therapies and Key Companies in the Therapeutics Domain
- Smart Hospital: How it is Shaping the Future of Healthcare Delivery
- An in-depth Assessment of the Top Drugs Launched by Leading Global Companies in 2021
About Delveinsight:
DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.
Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
Site Title 